相关实验视频
Updated: Jul 18, 2025

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
43.8K
内皮功能障碍,血小板过活,高血压和代谢综合征:分子见解和打击策略
Diptimayee Das1, Nagainallur Ravichandran Shruthi1, Antara Banerjee1
1Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.
Frontiers in nutrition
|August 24, 2023
概括
代谢综合征 (MetS) 管理需要全面的方法,优先考虑生活方式的改变,以及医疗和营养药物干预. 本综述探讨了在MetS患者中解决高血压,内皮功能障碍和血小板功能障碍的策略.
科学领域:
- 心脏病学和新陈代谢健康
背景情况:
- 代谢综合征 (MetS) 是一个日益严重的全球健康问题,增加了动脉样硬化心血管疾病的风险.
- 甲状腺综合症的关键组成部分包括肥胖,高血压,脂质失调和高血糖症,以及内皮和血小板功能障碍.
研究的目的:
- 审查治疗MetS的病因学,分子机制和饮食策略.
- 专注于在MetS中对抗高血压,内皮功能障碍和血小板功能障碍.
主要方法:
- 文献综述综合了当前关于MetS的研究.
- 分子机制和饮食干预措施的分析.
- 药理学和营养药学方法的探索.
主要成果:
- 改变生活方式是MetS的主要治疗策略.
- 治疗的组合,包括药物治疗,生活方式的改变和营养药,往往是必要的.
- 特定的饮食策略可以针对关键的MetS相关功能障碍.
结论:
- 有效的 MetS 管理需要一个多方面的战略.
- 解决高血压,内皮功能障碍和血小板功能障碍对于降低MetS中心血管风险至关重要.
- 整合生活方式,药物和营养药物干预措施为MetS患者提供了有希望的前景.
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
562
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
562
Hypertension II: Pathophysiology
15
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
15
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10

